Retifanlimab is an anti-programmed cell death protein 1 (anti-PD-1) monoclonal antibody (mAb). Retifanlimab can be used for the research of gastroesophageal adenocarcinoma (GEA).
Purity:
>95.0%
CAS Number:
[2079108-44-2]
Target:
PD-1/PD-L1
* VAT and and shipping costs not included. Errors and price changes excepted